Cargando…

3D printing of pharmaceuticals for disease treatment

Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakka, L. R. Jaidev, Chede, Shanthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871616/
https://www.ncbi.nlm.nih.gov/pubmed/36704231
http://dx.doi.org/10.3389/fmedt.2022.1040052
_version_ 1784877216339853312
author Chakka, L. R. Jaidev
Chede, Shanthi
author_facet Chakka, L. R. Jaidev
Chede, Shanthi
author_sort Chakka, L. R. Jaidev
collection PubMed
description Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients to facilitate the stages of blending, mixing, pressing, releasing, and packaging. In some cases, these excipients cause serious side effects to the patients. The 3D printing of pharmaceutical manufacturing avoids the need for excessive excipients. The two major components of a 3D printed tablet or dosage form are polymer matrix and drug component alone. Hence the usage of the 3D printed dosage forms for disease treatment will avoid unwanted side effects and provide higher therapeutic efficacy. With respect to the benefits of the 3D printed pharmaceuticals, the present review was constructed by discussing the role of 3D printing in producing formulations of various dosage forms such as fast and slow releasing, buccal delivery, and localized delivery. The dosage forms are polymeric tablets, nanoparticles, scaffolds, and films employed for treating different diseases.
format Online
Article
Text
id pubmed-9871616
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98716162023-01-25 3D printing of pharmaceuticals for disease treatment Chakka, L. R. Jaidev Chede, Shanthi Front Med Technol Medical Technology Three-dimensional (3D) printing or Additive manufacturing has paved the way for developing and manufacturing pharmaceuticals in a personalized manner for patients with high volume and rare diseases. The traditional pharmaceutical manufacturing process involves the utilization of various excipients to facilitate the stages of blending, mixing, pressing, releasing, and packaging. In some cases, these excipients cause serious side effects to the patients. The 3D printing of pharmaceutical manufacturing avoids the need for excessive excipients. The two major components of a 3D printed tablet or dosage form are polymer matrix and drug component alone. Hence the usage of the 3D printed dosage forms for disease treatment will avoid unwanted side effects and provide higher therapeutic efficacy. With respect to the benefits of the 3D printed pharmaceuticals, the present review was constructed by discussing the role of 3D printing in producing formulations of various dosage forms such as fast and slow releasing, buccal delivery, and localized delivery. The dosage forms are polymeric tablets, nanoparticles, scaffolds, and films employed for treating different diseases. Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9871616/ /pubmed/36704231 http://dx.doi.org/10.3389/fmedt.2022.1040052 Text en © 2023 Chakka and Chede. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medical Technology
Chakka, L. R. Jaidev
Chede, Shanthi
3D printing of pharmaceuticals for disease treatment
title 3D printing of pharmaceuticals for disease treatment
title_full 3D printing of pharmaceuticals for disease treatment
title_fullStr 3D printing of pharmaceuticals for disease treatment
title_full_unstemmed 3D printing of pharmaceuticals for disease treatment
title_short 3D printing of pharmaceuticals for disease treatment
title_sort 3d printing of pharmaceuticals for disease treatment
topic Medical Technology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871616/
https://www.ncbi.nlm.nih.gov/pubmed/36704231
http://dx.doi.org/10.3389/fmedt.2022.1040052
work_keys_str_mv AT chakkalrjaidev 3dprintingofpharmaceuticalsfordiseasetreatment
AT chedeshanthi 3dprintingofpharmaceuticalsfordiseasetreatment